Diaxonhit Awarded $2.4M to Develop HIV CDx | GenomeWeb

NEW YORK (GenomeWeb) – Diaxonhit today said that Bpifrance has granted it more than €1.7 million ($2.4 million) to develop a companion diagnostic for an AIDS vaccine under development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.